Ameritas Investment Partners’s Amedisys AMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-6,359
| Closed | -$626K | – | 3146 |
|
|
2025
Q2 | $626K | Sell |
6,359
-202
| -3% | -$19.1K | 0.02% | 760 |
|
|
2025
Q1 | $608K | Sell |
6,561
-134
| -2% | -$12.4K | 0.02% | 745 |
|
|
2024
Q4 | $608K | Hold |
6,695
| – | – | 0.02% | 755 |
|
|
2024
Q3 | $646K | Sell |
6,695
-246
| -4% | -$24K | 0.02% | 751 |
|
|
2024
Q2 | $637K | Sell |
6,941
-378
| -5% | -$35.1K | 0.02% | 731 |
|
|
2024
Q1 | $675K | Hold |
7,319
| – | – | 0.02% | 732 |
|
|
2023
Q4 | $696K | Hold |
7,319
| – | – | 0.03% | 710 |
|
|
2023
Q3 | $684K | Sell |
7,319
-818
| -10% | -$75.6K | 0.03% | 681 |
|
|
2023
Q2 | $744K | Sell |
8,137
-8,306
| -51% | -$681K | 0.03% | 672 |
|
|
2023
Q1 | $1.21M | Buy |
16,443
+8,100
| +97% | +$701K | 0.05% | 503 |
|
|
2022
Q4 | $800K | Sell |
8,343
-7,900
| -49% | -$712K | 0.03% | 656 |
|
|
2022
Q3 | $1.57M | Buy |
16,243
+799
| +5% | +$95.3K | 0.07% | 326 |
|
|
2022
Q2 | $1.62M | Hold |
15,444
| – | – | 0.07% | 336 |
|
|
2022
Q1 | $2.66M | Hold |
15,444
| – | – | 0.1% | 221 |
|
|
2021
Q4 | $2.5M | Hold |
15,444
| – | – | 0.08% | 256 |
|
|
2021
Q3 | $2.3M | Sell |
15,444
-160
| -1% | -$33.3K | 0.08% | 257 |
|
|
2021
Q2 | $3.82M | Sell |
15,604
-264
| -2% | -$69.3K | 0.14% | 127 |
|
|
2021
Q1 | $4.39M | Hold |
15,868
| – | – | 0.17% | 87 |
|
|
2020
Q4 | $4.65M | Sell |
15,868
-124
| -0.8% | -$31.8K | 0.21% | 73 |
|
|
2020
Q3 | $3.78M | Sell |
15,992
-175
| -1% | -$39.8K | 0.17% | 93 |
|
|
2020
Q2 | $3.21M | Sell |
16,167
-2,462
| -13% | -$459K | 0.15% | 110 |
|
|
2020
Q1 | $3.42M | Sell |
18,629
-9
| -0% | -$1.6K | 0.19% | 79 |
|
|
2019
Q4 | $3.11M | Sell |
18,638
-1,170
| -6% | -$174K | 0.14% | 132 |
|
|
2019
Q3 | $2.6M | Buy |
19,808
+469
| +2% | +$61.1K | 0.12% | 171 |
|
|
2019
Q2 | $2.35M | Buy |
19,339
+8,559
| +79% | +$1.02M | 0.11% | 195 |
|
|
2019
Q1 | $1.33M | Buy |
10,780
+8,560
| +386% | +$1.07M | 0.06% | 388 |
|
|
2018
Q4 | $260K | Buy |
2,220
+125
| +6% | +$14.7K | 0.01% | 859 |
|
|
2018
Q3 | $262K | Sell |
2,095
-186
| -8% | -$20.5K | 0.01% | 941 |
|
|
2018
Q2 | $195K | Sell |
2,281
-134
| -6% | -$9.84K | 0.01% | 1080 |
|
|
2018
Q1 | $146K | Hold |
2,415
| – | – | 0.01% | 1257 |
|
|
2017
Q4 | $127K | Hold |
2,415
| – | – | 0.01% | 1362 |
|
|
2017
Q3 | $126K | Hold |
2,415
| – | – | 0.01% | 1317 |
|
|
2017
Q2 | $152K | Hold |
2,415
| – | – | 0.01% | 1201 |
|
|
2017
Q1 | $123K | Buy |
+2,415
| New | +$115K | 0.01% | 1307 |
|
Other funds holding AMED
IA
MCI
HNB
Ameritas Investment Partners's AMED Position: Q3 2025 in Review
Ameritas Investment Partners sold out of Amedisys (AMED) in Q3 2025, closing a stake of 6,359 shares — an estimated $626K sold.
Ameritas Investment Partners first reported a position in AMED in Q1 2017 and held it in 34 quarters. The position peaked at $4.65M in Q4 2020. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.
- Ameritas Investment Partners reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
- Ameritas Investment Partners sold 6,359 Amedisys shares in Q3 2025, an estimated $626K.
- Ameritas Investment Partners first reported a position in Amedisys in Q1 2017 and held it in 34 quarters.
- Ameritas Investment Partners's Amedisys position peaked at $4.65M in Q4 2020.
- 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.
Based on Ameritas Investment Partners's 13F filing for Q3 2025, filed 10 Nov 2025.